The Comparative Safety and Effectiveness of dabigatran, versus rivaroxaban, and apixaban Utilized in the Department of Defense (DoD) Non-Valvular Atrial Fibrillation Patient Population-A Retrospective Database Analysis First published 02/12/2016 Last updated 02/04/2024 EU PAS number:EUPAS16528 Study Finalised